Literature DB >> 177729

Effect of ammonium 5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infections in mice.

G H Werner, C Jasmin, J C Chermann.   

Abstract

Ammonium 5-tungsto-2-antimoniate (HPA 23) protected micr partially or completely against two strains of encephalomyocarditis (EMC) virus and one strain of vesicular stomatitis (VSV) virus. The best protective effect was obtained with EMC strain VR 129 and VSV when a single i.p. injection of HPA 23 was administered shortly before virus inoculation. Mice protected by HPA 23 against EMC strain VR129 had virus titres in the blood and brain similar to those in untreated mice. A synergism between interferon and HPA 23 was observed in mice infected with EMC VR129. Our results demonstrate the in vivo activity of HPA 23 against two lethal viral infections and suggest that, at least in mice infected with EMC, death may not be related solely to virus multiplication.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 177729     DOI: 10.1099/0022-1317-31-1-59

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  Ammonium-5-tungsto-2-antimoniate (HPA23) can prevent fox rabies.

Authors:  M Pepin; J Blancou
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

Review 2.  Management of infectious and immunological complications of acquired immunodeficiency syndrome (AIDS). Current and future prospects.

Authors:  C U Tuazon; A M Labriola
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

3.  Combined protective effects on interferon and interferon induction on herpes simplex and ectromelia virus infections in mice.

Authors:  J Imanishi; M Matsubara; C J Won; H Nomura; T Kishida
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

4.  The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection.

Authors:  R H Kimberlin; C A Walker
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

5.  Experimental transmission of an autosomal dominant spongiform encephalopathy: does the infectious agent originate in the human genome?

Authors:  H F Baker; R M Ridley; T J Crow
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-03

Review 6.  Picornavirus inhibitors.

Authors:  L Carrasco
Journal:  Pharmacol Ther       Date:  1994       Impact factor: 12.310

7.  Persistent viral infections as models for research in virus chemotherapy.

Authors:  G Streissle
Journal:  Adv Virus Res       Date:  1981       Impact factor: 9.937

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.